The Lynx Group
Association for Value-Based Care

COVID-19 Impact on the Cancer Care Delivery Ecosystem

LIVE Webcast Series

AVBCC COVID-19 Webcast Series Replays

August 27, 2020: Vaccines: COVID-19 Recovery, the Road Ahead
It is a Herculean effort to develop a novel vaccine on an unprecedented timeline. Experts discuss the latest research regarding the development of vaccine candidates for the COVID-19 virus and some of the issues that will need to be addressed when a successful candidate has been identified, including clinical trial enrollment, manufacturing, and distribution.
Read More

August 26, 2020: The Road to Recovery for Community Oncology Practices: COVID-19 Recovery, the Road Ahead
Community oncology practices say they are recovering from the COVID-19 pandemic and keeping their eye on the goal of value-based care. The strategies they are using to accomplish these initiatives include innovation, long-term integration of telehealth, and the leveraging of advanced practice professionals.
Read More

August 25, 2020: Oncology Nursing And Cancer Care Update: COVID-19 Recovery, the Road Ahead
The COVID-19 pandemic has created significant barriers to care, which can lead to increased mortality rates for thousands of patients with cancer. Nurses and nurse navigators are focused on using their skills and experience to combat this trend. Ongoing efforts include educating patients on the importance of undergoing cancer screenings, utilizing telehealth services to enhance communication with patients, addressing staffing shortages, and taking the necessary steps for preparing for potential spikes in COVID-19 cases.
Read More

August 20, 2020: Update on Economic Observations: COVID-19 Recovery, the Road Ahead
Although several of the financial indicators in oncology have recovered to pre-pandemic levels following dramatic declines that occurred earlier in the year, there are still significant challenges ahead. How will providers manage the backlog? What will happen to patients’ insurance coverage? How will oncology practices survive and thrive in a post–COVID-19 world?
Read More

August 19, 2020: Update on Wholesale Supply Channels: COVID-19 Recovery, the Road Ahead
From the management of extended payment terms and performance-based agreements, to the potential impact of the proposed 2021 Medicare rules and the impending shortages of immune globulin, wholesale suppliers discuss how the COVID-19 pandemic continues to affect the oncology supply chain, what is being done to help practices, and what challenges lie ahead.
Read More

August 18, 2020: Telehealth Update: COVID-19 Recovery, the Road Ahead
Can the use of telehealth services help to address the upcoming burden of late cancer diagnoses, improve the co-management of chronic conditions, and give patients more power over their own health? During a recent AVBCC webinar, a panel of experts explored this question as they discussed the potential role of wearables, remote monitoring and communication, and other innovative technology for improving care for patients with cancer.
Read More

August 14, 2020: Update on Research and Investigational Studies: COVID-19 Recovery, the Road Ahead
With many clinical trials on hold and COVID-19 studies the only new trials opening up, how are cancer researchers adapting to the new environment? Can lessons from COVID-19 facilitate improved clinical trial recruitment and retention in the future?
Read More

August 13, 2020: Washington and Public Policy Update: COVID-19 Recovery, the Road Ahead
Telehealth reimbursement. 340B. Drug pricing negotiations. There’s been a lot of action on healthcare-related proposals in Washington in recent weeks. What’s likely to last, and what is just “political theater”? AVBCC’s panel of experts has the inside scoop.
Read More

August 12, 2020: Update From Employers: COVID-19 Recovery, the Road Ahead
With the chaos in the workplace and in healthcare caused by the COVID-19 pandemic, experts predict that most major employers will not be looking to add any more disruption with significant changes to their benefit plans for 2021.
Read More

August 11, 2020: Update on Pharmaceutical Manufacturers: COVID-19 Recovery, the Road Ahead
Initiatives to expand patient access programs, strategies to secure the supply chain, and updates on vaccine trials: leaders from top pharmaceutical manufacturers discussed their companies’ ongoing response to the worldwide pandemic in this AVBCC webcast.
Read More

Page 1 of 4

Donations

All of our events are free to anyone who may be interested; however, we are accepting donations to offset the cost of the event with any additional proceeds to directly fund the efforts of first responders and front-line healthcare professionals working tirelessly to save lives during this time of national crisis. Tax deductible donations can be made through the AONN+ Foundation for Learning, a 501(c)(3) organization.

Disclaimer: Funding from these donations to the AONN+ Foundation for Learning will not be used for certification purposes. These funds will solely cover the cost of the event, and all remaining proceeds will be donated to first responders and front-line healthcare professionals. By making a donation you are not entitled to any special benefits; a donation has no direct impact or influence on decisions on certification.

Thank You to Our Webcast Series Supporters

  • Cardinal Health

    Captain

  • Flatiron

    Captain

  • Foundation Medicine

    Captain

  • Integra Connect

    Captain

  • Lilly Oncology

    Captain

  • Mylan

    Captain

  • Pfizer

    Captain

  • Sun Pharma

    Captain

  • AmerisourceBergen

    Lieutenant

  • Amgen Oncology

    Lieutenant

  • Bristol-Myers Squibb

    Lieutenant

  • Merck

    Lieutenant

  • Pharmacyclics + Janssen

    Lieutenant

  • Sanofi Genzyme

    Lieutenant

  • Daiichi Sankyo

    Major

  • Eisai

    Major

  • FFF Enterprises

    Major

  • Swim Across America

    Major

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: